Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J McCann

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|January 24, 2008
Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disordersD J McCann
International Journal of Sports Medicine|January 30, 2004
Body size and V.O2peak: a new perspective?D J McCann
European Journal of Pharmacology|April 25, 1990
Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractionsD J McCann, T P Su
Neuroscience Letters|July 20, 1992
Tris inhibits (+)-[3H]SKF-10,047 binding to sigma receptorsD J McCann, T P Su
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranesD J McCann, T P Su
Pharmacology, Biochemistry, and Behavior|February 1, 1986
Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial mazeD J McCann, J C Winter
Medicine and Science in Sports and Exercise|July 1, 1997
Wet bulb globe temperature index and performance in competitive distance runnersD J McCann, W C Adams
European Journal of Pharmacology|May 16, 1990
Haloperidol competitively inhibits the binding of (+)-[3H]SKF-10,047 to sigma sitesD J McCann, T P Su
Biochimica Et Biophysica Acta|May 13, 1993
Aryl sulfotransferase-IV-catalyzed sulfation of aryl oximes: steric and substituent effectsJ B Mangold, D J McCann, A Spina
Biochimica Et Biophysica Acta|June 27, 1989
Sulfation of mono- and diaryl oximes by aryl sulfotransferase isozymesJ B Mangold, A Spina, D J McCann
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|January 24, 2008
Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disordersD J McCann
International Journal of Sports Medicine|January 30, 2004
Body size and V.O2peak: a new perspective?D J McCann
European Journal of Pharmacology|April 25, 1990
Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractionsD J McCann, T P Su
Neuroscience Letters|July 20, 1992
Tris inhibits (+)-[3H]SKF-10,047 binding to sigma receptorsD J McCann, T P Su
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranesD J McCann, T P Su
Pharmacology, Biochemistry, and Behavior|February 1, 1986
Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial mazeD J McCann, J C Winter
Medicine and Science in Sports and Exercise|July 1, 1997
Wet bulb globe temperature index and performance in competitive distance runnersD J McCann, W C Adams
European Journal of Pharmacology|May 16, 1990
Haloperidol competitively inhibits the binding of (+)-[3H]SKF-10,047 to sigma sitesD J McCann, T P Su
Biochimica Et Biophysica Acta|May 13, 1993
Aryl sulfotransferase-IV-catalyzed sulfation of aryl oximes: steric and substituent effectsJ B Mangold, D J McCann, A Spina
Biochimica Et Biophysica Acta|June 27, 1989
Sulfation of mono- and diaryl oximes by aryl sulfotransferase isozymesJ B Mangold, A Spina, D J McCann
Pageof 3